Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


Drugs that rate on Twitter

Posted 25 February 2021 AM

Three drugs have been revealed as the most actively discussed and hashtagged on Twitter in the area of inflammatory arthritic diseases, according to a new drug watch analysis.

Pfizer's tofacitinib, sold under the brand name Xeljanz,  AbbVie's upadacitinib sold as Rinvoq and Gilead's filgotinib sold as Jyseleca have been "hot topics" of discussion with many patients curious about new approvals and the impact of  the immune-suppressing drugs and COVID-19.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
All fine, nothing to see here
How politics made a mess of the rollout
Special Report
PBAC July Agenda
Committee to assess 36 submissions
Approvals Action
First copy of gout drug
Plus new formulations of PBS-listed drugs
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas